Abstract
The dystrophin gene, located at chromosome Xp21, was evaluated as a candidate gene in chronic schizophrenia in response to the report of a large family in which schizophrenia cosegregated with Becker muscular dystrophy [Zatz et al., 1991: Am J Hum Genet 49: A364; 1992: J Med Genet 30(2):131- 134]. Genomic DNA from 94 men with chronic schizophrenia was evaluated by Southern blot analysis using cDNA probes that span exons 1-59. No exonic deletions were identified. An unexpectedly high rate of polymorphism was calculated in this study and two novel polymorphisms were found, demonstrating the usefulness of the candidate gene approach even when results of the original study are negative.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1-4 |
| Number of pages | 4 |
| Journal | American journal of medical genetics |
| Volume | 54 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 1994 |
Keywords
- dystrophin gene
- polymorphism
- polymorphism rate
- schizophrenia
ASJC Scopus subject areas
- Genetics
- Genetics(clinical)
Fingerprint Dive into the research topics of 'Screening the dystrophin gene suggests a high rate of polymorphism in general but no exonic deletions in schizophrenics'. Together they form a unique fingerprint.
Cite this
Lindor, N. M., Sobell, J. L., Heston, L. L., Thibodeau, S. N., & Sommer, S. S. (1994). Screening the dystrophin gene suggests a high rate of polymorphism in general but no exonic deletions in schizophrenics. American journal of medical genetics, 54(1), 1-4. https://doi.org/10.1002/ajmg.1320540102